June 20, 2024 at 11:24PM FDA Expands Approval of Gene Therapy for Patients with Duchenne Muscular Dystrophy

The FDA expanded the approval of Elevidys, a gene therapy for the treatment of Duchenne muscular dystrophy for ambulatory and non-ambulatory individuals 4 years of age and older with DMD with a confirmed mutation in the DMD gene.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/t6MIYE8